Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
05/2010
05/11/2010US7714106 Neuropeptides and their use for pest control
05/11/2010US7714105 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis
05/11/2010US7714063 Solid support for Fmoc-solid phase synthesis of peptides
05/11/2010US7714020 Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
05/11/2010CA2438260C Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
05/11/2010CA2392570C 4-pyrimidinyl-n-acyl-l-phenylalanines
05/06/2010WO2010050508A1 Peptide having anti-diabetic activity and use thereof
05/06/2010WO2010050485A1 Refolding agents and protein refolding method
05/06/2010WO2010050448A1 Peptide-containing culture medium for culturing animal cell
05/06/2010WO2010049369A1 Piperazine compounds with herbicidal effect
05/06/2010US20100113770 O-substituted hydroxyaryl derivatives
05/06/2010US20100113579 Prodrugs of excitatory amino acids
05/06/2010US20100113369 Means for preventing and treating cellular death and their biological applications
05/06/2010US20100113368 Cholesterol lowering protein hydrolysates
05/06/2010US20100113356 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
05/06/2010US20100113328 Targeted delivery to legumain-expressing cells
05/06/2010US20100112635 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
05/06/2010US20100111871 Photoacoustic probes and methods of imaging
05/06/2010DE102009035593A1 N-terminal modifizierte Tetrapeptidderivate mit C-terminalem Argininmetikum N-terminally modified tetrapeptide derivatives with C-terminal Argininmetikum
05/06/2010CA2739712A1 Peptide having anti-diabetic activity and use thereof
05/05/2010EP2181101A2 Tubulysin d analogues
05/05/2010EP1790655B1 Biologically active peptides
05/05/2010EP1232157B1 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
05/05/2010CN1976947B Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives
05/05/2010CN1446261B Modified cytokines for use in cancer therapy
05/05/2010CN101701032A Quinoxalinone low molecular weight peptide derivative with matrix metalloproteinases inhibition function and preparation method and application thereof
05/04/2010US7709600 Interaction between the VHL tumor suppressor and hypoxia inducible factor, and assay methods relating thereto
05/04/2010US7709443 For treatment of human melanoma, pancreatic, breast, prostate cancer cells
05/04/2010CA2318494C Angiotensin converting enzyme inhibitor
05/04/2010CA2221568C Metabolic effects of certain glutathione analogs
04/2010
04/29/2010WO2010046900A2 Rgd-containing peptidomimetics and uses thereof
04/29/2010WO2010046298A2 Improved peptide availability
04/29/2010US20100105914 Caspase inhibitors and uses thereof
04/29/2010US20100105864 Prophylactic or therapeutic agent for diarrhea
04/29/2010US20100105609 Processes for Preparing Eptifibatide
04/29/2010US20100105567 Novel capture agents for binding a ligand
04/29/2010US20100104576 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization;
04/29/2010US20100104521 Cosmetic and/or pharmaceutical composition comprising as an active principle at least one peptide and use of this peptide
04/29/2010CA2741207A1 Rgd-containing peptidomimetics and uses thereof
04/28/2010EP2180061A1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester
04/28/2010EP2180060A1 Method for produding alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester
04/28/2010EP2180059A1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester
04/28/2010EP2180027A1 Novel lipid-tripeptide based hydrogel-forming agent and hydrogel
04/28/2010EP2178902A1 Macrocyclic compounds as antiviral agents
04/28/2010EP2178888A1 Proteasome inhibitors
04/28/2010CN1809586B Biologically active peptide comprising tyrosyl-seryl-valine (YSV)
04/28/2010CN1795183B Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
04/28/2010CN1731934B Ace inhibitory peptides from plant materials
04/28/2010CN1688600B Template-fixed peptidomimetics with antibacterial activity
04/28/2010CN1658855B O-substituted hydroxyaryl derivatives
04/27/2010USRE41288 increasing insulinotropic response in ischemia and treating reperfusion and injured brain cells after an ischemic event by administering glucagon-like peptide-1 and a pharmaceutical carrier for a time sufficient and under conditions effective to increase insulinotropic response which produces insulin
04/27/2010US7705118 Methods for preparing internally constrained peptides and peptidomimetics
04/27/2010US7705050 Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils
04/27/2010US7705006 Anti-cancer cyclopenta[g]quinazoline compounds
04/27/2010US7704969 Transfection complexes
04/27/2010US7704955 polypeptide which can be used to treat, prevent, and modulate pain, inflammation, and metabolic processes in various organisms including plants and animals
04/27/2010US7704954 Method and carrier complexes for delivering molecules to cells
04/27/2010US7704924 Library of compounds comprising pyrrolobenzodiazepine moieties
04/27/2010US7704703 Identifying modulators of tumor suppressor protein activity for use in treatment and prevention of infection and cell proliferative disorders
04/27/2010CA2374377C Potassium channel kcnq5
04/27/2010CA2321149C Antitumor agents
04/27/2010CA2203758C Compositions for the detection of proteases in biological samples and methods of use thereof
04/22/2010WO2010045266A1 Therapeutic antiviral peptides
04/22/2010US20100099847 Crystal of glutathione and process for production thereof
04/22/2010US20100099846 Depsipeptide containing lactic acid residue
04/22/2010US20100099843 Dolastatin 15 derivatives
04/22/2010US20100099786 Carbamate, thiocarbamate or carbamide comprising a biomolecular moiety
04/22/2010US20100099727 Amino acid and peptide conjugates of arylalkylic acids for cosmetic use
04/22/2010US20100099657 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity
04/22/2010US20100099627 Nuclear targeting sequences
04/22/2010US20100098769 Synthetic Peptides Reducing or Removing Bags Formed Under the Lower Eye Contour and Their Use in Cosmetic or Dermopharmaceutical Compositions
04/22/2010US20100098748 Arg-Gly-Asp (RGD) Sequence Containing Cyclic Peptide and Its Active Targeting Liposomes
04/22/2010DE102008042932A1 Herstellung und Verwendung von Methionylmethionin als Futtermitteladditiv für Fische und Krustentiere Production and use of methionylmethionine as a feed additive for fish and crustaceans
04/22/2010CA2740728A1 Therapeutic antiviral peptides
04/21/2010EP2177529A1 Novel -secretase inhibitor
04/21/2010EP1635692B1 Monitoring immunologic, hematologic and inflammatory diseases
04/21/2010CN1978462B Imidazoline modified amino acid, and its synthesizing method and use for polypeptide marking
04/21/2010CN101696232A Peptidomimetic protease inhibitors
04/21/2010CN101696231A Antigen epitope minimum motif peptide of human papilloma virus 58 type E6 protein
04/20/2010USRE41252 Peptidyl prodrugs and linkers and stabilizers useful therefor
04/20/2010US7700765 DNA minor groove binding compounds
04/20/2010US7700719 Mutant protofibril for active immunisation; synuclein genes, proteins; point mutations; Parkinson's disease; dementia; host cells
04/20/2010US7700715 Kit for use in the diagnosis and treatment of cancer
04/20/2010US7700560 Compounds comprising two human GlxI inhibitors covalently linked via a diacid where each of the inhibitors may be the same or different and is an S-substituted glutathione or a prodrug thereof having a gamma-glutamyl amino group; length >50 Angstroms; antitumor, -carcinogenic, -proliferative agents
04/20/2010US7700304 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening
04/20/2010CA2359964C Method for preparing bicyclic compounds and use of said method for preparing an interleukin-1-.beta. conversion enzyme (ice) inhibitor
04/15/2010WO2010041699A1 Btma2 compound
04/15/2010WO2010040660A1 Pseudoproline dipeptides
04/15/2010WO2010021717A3 Hcv protease inhibitors
04/15/2010WO2010020825A3 Urocortin 3 fragments and analogs, their preparation and use as antidepressive and anxiolytic agents
04/15/2010WO2009006246A8 Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome
04/15/2010US20100093831 Nucleic acid compounds for inhibiting angiogenesis and tumor growth
04/15/2010US20100093785 Diamine derivatives
04/15/2010US20100093737 Nucleoside and Nucleotide Analogues with Quaternary Carbon Centers and Methods of Use
04/15/2010US20100093645 SMAC Peptidomimetics and the Uses Thereof
04/15/2010US20100093644 Template-fixed peptidomimetics
04/15/2010US20100093643 Cardioprotective compounds
04/15/2010US20100093641 Silk protein-mimicking peptides and compositions for preventing or treating cranial neuropathies comprising the same
04/15/2010US20100093624 Peptide therapeutics that bind vegf and methods of use thereof
04/15/2010US20100093612 Integrin targeted cyclopeptide ligands, their preparation and use
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 307